LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
2 hedge funds and large institutions have $42.1K invested in LianBio American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $47.3K → $42.1K (-$5.14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
+$85 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
RhumbLine Advisers
Boston,
Massachusetts
| $39.1K | – | – | – |
|
|
FIA
2
FNY Investment Advisers
New York
| $3K | +$85 | +400 | +3% |
|
LIAN Hedge Fund Activity: Q4 2024 in Review
2 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q4 2024, worth a combined $42.1K — down 11% from $47.3K a quarter earlier.
Fund positioning in LIAN was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was FNY Investment Advisers, adding an estimated $85.
- 2 institutional investors held LianBio American Depositary Shares (LIAN) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $42.1K of LianBio American Depositary Shares stock for Q4 2024, down 11% quarter-over-quarter.
- 0 funds opened new LianBio American Depositary Shares positions in Q4 2024 and 0 closed out.
- The largest LianBio American Depositary Shares buyer in Q4 2024 was FNY Investment Advisers, an estimated $85 added.
Based on aggregated 13F filings for Q4 2024.